Catalyst Wire Dossier Catalyst Wire Dossier

Telmisartan/amlodipine 80/5

telmisartan/amlodipine · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Telmisartan/amlodipine 80/5, covering 2009-12-15 to 2009-12-15. Get the full timeline:

Most recent: Clinical Trial Update: Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension [Phase 3]

See pricing